Literature DB >> 17905235

The use of controlled ovarian hyperstimulation (COH) in clinical in vitro fertilization: the role of Georgeanna Seegar Jones.

Howard W Jones1.   

Abstract

The use of controlled ovarian hyperstimulation (COH) to recruit multiple oocytes is now common practice worldwide in most clinical programs of in vitro fertilization (IVF). It was not always so. This is the story of the first successful use of exogenous gonadotropins in a clinical program of IVF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905235     DOI: 10.1016/j.fertnstert.2007.07.1333

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Best practices for controlled ovarian stimulation in in vitro fertilization.

Authors:  Emily S Jungheim; Melissa F Meyer; Darcy E Broughton
Journal:  Semin Reprod Med       Date:  2015-03-03       Impact factor: 1.303

Review 2.  History and challenges surrounding ovarian stimulation in the treatment of infertility.

Authors:  Stephanie A Beall; Alan DeCherney
Journal:  Fertil Steril       Date:  2012-04       Impact factor: 7.329

3.  Analysis of follicular fluid retinoids in women undergoing in vitro fertilization: retinoic acid influences embryo quality and is reduced in women with endometriosis.

Authors:  Samuel A Pauli; Donna R Session; Weirong Shang; Kirk Easley; Friedrich Wieser; Robert N Taylor; Keely Pierzchalski; Joseph L Napoli; Maureen A Kane; Neil Sidell
Journal:  Reprod Sci       Date:  2013-02-20       Impact factor: 3.060

Review 4.  What are the risks of the assisted reproductive technologies (ART) and how can they be minimized?

Authors:  Robert W Rebar
Journal:  Reprod Med Biol       Date:  2013-06-11

Review 5.  The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.

Authors:  Bruno Lunenfeld; Wilma Bilger; Salvatore Longobardi; Veronica Alam; Thomas D'Hooghe; Sesh K Sunkara
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-03       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.